TC LPA5 4 manufacturers
- TC LPA5 4
-
- $44.00
-
2026-07-15
- CAS:1393814-38-4
- Purity: 99.93%
- Supply Ability: 10g
|
| | TC LPA5 4 Basic information |
| Product Name: | TC LPA5 4 | | Synonyms: | TC LPA5 4;BNALUYKEGYUHQC-UHFFFAOYSA-N;5-(3-Chloro-4-cyclohexylphenyl)-1-(3-methoxyphenyl)-1H-pyrazole-3-carboxylic acid;1H-Pyrazole-3-carboxylic acid, 5-(3-chloro-4-cyclohexylphenyl)-1-(3-methoxyphenyl)-;TC LPA5 4,TC LPA-5 4 | | CAS: | 1393814-38-4 | | MF: | C23H23ClN2O3 | | MW: | 410.89 | | EINECS: | | | Product Categories: | | | Mol File: | 1393814-38-4.mol |  |
| | TC LPA5 4 Chemical Properties |
| Boiling point | 600.4±55.0 °C(Predicted) | | density | 1.31±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO:41.09(Max Conc. mg/mL);100.0(Max Conc. mM)
Ethanol:8.22(Max Conc. mg/mL);20.0(Max Conc. mM) | | form | Solid | | pka | 3.75±0.10(Predicted) | | color | Light yellow to yellow |
| | TC LPA5 4 Usage And Synthesis |
| Uses | TC LPA5 4 is a LPA5 receptor antagonist. It inhibits LPA-induced aggregation of isolated human platelets and exhibits selectivity for LPA5 against 80 other screened targets. | | in vivo | TC LPA5 4 (10 mg/kg; intraperitoneal injection; 5 days/week for 2 weeks) could delay CGTH-W3 xenograft growth in nude mice[2]. | Animal Model: | BALB/C nu/nu mice, aged 4 5 weeks (CGTH-W3 xenografts) [2] | | Dosage: | 10 mg/kg | | Administration: | Intraperitoneal injection; 5 days/week for 2 weeks | | Result: | Significantly inhibits CGTH-W3 xenograft growth with inhibitory rates of 46.7%.
|
| | storage | Store at +4°C |
| | TC LPA5 4 Preparation Products And Raw materials |
|